Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other Non-Current Assets (2016 - 2025)

Iradimed (IRMD) has disclosed Other Non-Current Assets for 13 consecutive years, with $239000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 32.49% to $239000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $239000.0 through Dec 2025, down 32.49% year-over-year, with the annual reading at $239000.0 for FY2025, 32.49% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $239000.0 at Iradimed, up from $214374.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $648672.0 in Q4 2022, with the low at $172272.0 in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $252178.6, with a median of $210191.5 recorded in 2025.
  • The sharpest move saw Other Non-Current Assets surged 222.2% in 2022, then tumbled 72.03% in 2023.
  • Over 5 years, Other Non-Current Assets stood at $201325.0 in 2021, then soared by 222.2% to $648672.0 in 2022, then crashed by 72.03% to $181449.0 in 2023, then skyrocketed by 95.1% to $354000.0 in 2024, then plummeted by 32.49% to $239000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $239000.0, $214374.0, and $204499.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.